Acasti Pharma (ACST) Stock Price, News & Analysis
Company Description
Acasti Pharma (NASDAQ: ACST) is a publicly traded medicinal and botanical manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $34.2M, ranking #6,036 among all listed U.S. companies by market cap.
ACST stock has gained 42.2% over the past year. Shares last traded at $3.41.
This page provides a comprehensive overview of ACST stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Acasti Pharma (ACST) stock last traded at $3.41. Over the past 12 months, the stock has gained 42.2%. At a market capitalization of $34.2M, ACST is classified as a micro-cap stock with approximately 10.1M shares outstanding.
ACST Rankings
Latest News
Acasti Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, conferences, earnings. View all ACST news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACST Company Profile & Sector Positioning
Acasti Pharma (ACST) operates in the Medicinal and Botanical Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.